Cargando…

The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road?

In different large-scale clinic outcome trials, sodium (Na(+))/glucose co-transporter 2 (SGLT2) inhibitors showed profound cardiac- and renal-protective effects, making them revolutionary treatments for heart failure and kidney disease. Different theories are proposed according to the emerging prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jiang, Tian, Jiang, Sodhi, Komal, Shapiro, Joseph I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595165/ https://www.ncbi.nlm.nih.gov/pubmed/34297135 http://dx.doi.org/10.1007/s00232-021-00192-z

Ejemplares similares

The Redox-Sensitive Na/K-ATPase Signaling in Uremic Cardiomyopathy
por: Liu, Jiang, et al.
Publicado: (2020)

The Role of Na/K-ATPase Signaling in Oxidative Stress Related to Obesity and Cardiovascular Disease
por: Srikanthan, Krithika, et al.
Publicado: (2016)

Gene module regulation in dilated cardiomyopathy and the role of Na/K-ATPase
por: Gao, Yingnyu, et al.
Publicado: (2022)

Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
por: Hou, Yi-Chou, et al.
Publicado: (2020)

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
por: Salvatore, Teresa, et al.
Publicado: (2022)

pNaKtide inhibits Na/K-ATPase reactive oxygen species amplification and attenuates adipogenesis
por: Sodhi, Komal, et al.
Publicado: (2015)

Spin Trapping: A Review for the Study of Obesity Related Oxidative Stress and Na(+)/K(+)-ATPase
por: Nawab, Athar, et al.
Publicado: (2017)

The Role of Na/K-ATPase Signaling in Oxidative Stress Related to Aging: Implications in Obesity and Cardiovascular Disease
por: Bartlett, David E., et al.
Publicado: (2018)

Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy
por: Liu, Jiang, et al.
Publicado: (2016)

Oxidant-Induced Alterations in the Adipocyte Transcriptome: Role of the Na,K-ATPase Oxidant Amplification Loop
por: Sodhi, Komal, et al.
Publicado: (2020)

Corrigendum: Attenuation of Na/K-ATPase Mediated Oxidant Amplification with pNaKtide Ameliorates Experimental Uremic Cardiomyopathy
por: Liu, Jiang, et al.
Publicado: (2017)

Cardiorenal protection of SGLT2 inhibitors—Perspectives from metabolic reprogramming
por: Gao, Yue-Ming, et al.
Publicado: (2022)

Role of adipocyte Na,K-ATPase oxidant amplification loop in cognitive decline and neurodegeneration
por: Sodhi, Komal, et al.
Publicado: (2021)

Role of adipocyte Na,K-ATPase oxidant amplification loop in cognitive decline and neurodegeneration
por: Sodhi, Komal, et al.
Publicado: (2023)

SGLT2 Inhibitor–Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection
por: Herat, Lakshini Y., et al.
Publicado: (2020)

The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection
por: Brown, Emily, et al.
Publicado: (2021)

RETRACTED ARTICLE: The Na/K-ATPase Oxidant Amplification Loop Regulates Aging
por: Sodhi, Komal, et al.
Publicado: (2018)

Retraction Note: The Na/K-ATPase oxidant amplification loop regulates aging
por: Sodhi, Komal, et al.
Publicado: (2022)

Class effects of SGLT2 inhibitors on cardiorenal outcomes
por: Kluger, Aaron Y., et al.
Publicado: (2019)

Na/K-ATPase Signaling and Salt Sensitivity: The Role of Oxidative Stress
por: Liu, Jiang, et al.
Publicado: (2017)

Mechanistic Insight of Na/K-ATPase Signaling and HO-1 into Models of Obesity and Nonalcoholic Steatohepatitis
por: Pratt, Rebecca, et al.
Publicado: (2019)

Na/K-ATPase suppresses LPS-induced pro-inflammatory signaling through Lyn
por: Zhang, Jue, et al.
Publicado: (2022)

Protein Carbonylation of an Amino Acid Residue of the Na/K‐ATPase α1 Subunit Determines Na/K‐ATPase Signaling and Sodium Transport in Renal Proximal Tubular Cells
por: Yan, Yanling, et al.
Publicado: (2016)

Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology
por: Wang, Anzhu, et al.
Publicado: (2022)

Tumor-Suppressor Role of the α1-Na/K-ATPase Signalosome in NASH Related Hepatocellular Carcinoma †
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022)

The Na/K-ATPase Signaling: From Specific Ligands to General Reactive Oxygen Species
por: Pratt, Rebecca D., et al.
Publicado: (2018)

Metabolic Syndrome and Salt-Sensitive Hypertension in Polygenic Obese TALLYHO/JngJ Mice: Role of Na/K-ATPase Signaling
por: Yan, Yanling, et al.
Publicado: (2019)

Contribution of adipocyte Na/K-ATPase α1/CD36 signaling induced exosome secretion in response to oxidized LDL
por: Pillai, Sneha S., et al.
Publicado: (2023)

Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?
por: Verma, Subodh
Publicado: (2020)

Carbonylation Modification Regulates Na/K-ATPase Signaling and Salt Sensitivity: A Review and a Hypothesis
por: Shah, Preeya T., et al.
Publicado: (2016)

Quantum Modeling: A Bridge between the Pumping and Signaling Functions of Na/K-ATPase
por: Wang, Weiguang, et al.
Publicado: (2018)

Evidence for Cardiorenal Protection with SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Patients with Diabetic Kidney Disease
por: Georgianos, Panagiotis I., et al.
Publicado: (2022)

Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protection
por: Sridhar, Vikas S., et al.
Publicado: (2020)

RETRACTED ARTICLE: The Adipocyte Na/K-ATPase Oxidant Amplification Loop is the Central Regulator of Western Diet-Induced Obesity and Associated Comorbidities
por: Pratt, Rebecca D., et al.
Publicado: (2019)

Author Correction: The Adipocyte Na/K-ATPase Oxidant Amplification Loop is the Central Regulator of Western Diet-Induced Obesity and Associated Comorbidities
por: Pratt, Rebecca D., et al.
Publicado: (2020)

Retraction Note: The Adipocyte Na/K-ATPase Oxidant Amplification Loop is the Central Regulator of Western Diet-Induced Obesity and Associated Comorbidities
por: Pratt, Rebecca D., et al.
Publicado: (2022)

Protein Interaction and Na/K-ATPase-Mediated Signal Transduction
por: Cui, Xiaoyu, et al.
Publicado: (2017)

SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules
por: Wang, Yajiao, et al.
Publicado: (2023)

Uremic Toxins Activates Na/K-ATPase Oxidant Amplification Loop Causing Phenotypic Changes in Adipocytes in In Vitro Models
por: Bartlett, David E., et al.
Publicado: (2018)

RETRACTED ARTICLE: pNaKtide Attenuates Steatohepatitis and Atherosclerosis by Blocking Na/K-ATPase/ROS Amplification in C57Bl6 and ApoE Knockout Mice Fed a Western Diet
por: Sodhi, Komal, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tjfjsjo9v3r4d89irmfci72bti